Skip to main content
OpenTrials
Completed

NCT Number: NCT04895878

Patients With Co-occurrence of ANCA Vasculitis and Sjögren Syndrome

ANCA vasculitis and Sjögren syndrome are two rare diseases, and even more rarely associated. These two conditions have specific organ involvements, and specific follow-up.

The Investigators hypothesise that patients with co-occurrence of these two diseases may have a singular clinical course.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of ANCA vasculitis based on clinical, immunological and histopathological features.
  • Diagnosis of Sjögren syndrom based on ACR/EULAR 2016 criteria.

Exclusion criteria

  • Age < 18 years
  • Insuffisant data during follow-up

Treatment and study plan

Primary outcomes

  1. Severity of Sjögren disease

    Time frame: day 1 (Upon diagnosis)

    Severity of Sjögren disease

Secondary outcomes

  1. Sjögren extra-glandular complications

    Time frame: day 1 (Upon diagnosis)

    Sjögren extra-glandular complications

  2. severity of ANCA vasculitis

    Time frame: day 1 (Upon diagnosis)

    severity of ANCA vasculitis

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Registry information

Official study title

Patients With Co-occurrence of ANCA Vasculitis and Sjögren Syndrome : a Case Series and Systematic Review

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
May 20, 2021
Registry last updated
Sep 14, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.